Following the combined decitabine/PBA treatment of colon cancer cells, we observed a highly significant sixfold induced expression of XIST and a three- and twofold induction, respectively, of its target genes NDRG1 and SEMA6A. Here, NDRG1 is linked to colonic neoplasm.